Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients
BioCentury - Roche in $350M deal with Sommadossi's Atea for what it believes could be first oral COVID-19 antiviral
![Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20200331956/US20200331956A1-20201022-C00001.png "Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]")
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]
Jean-Pierre Sommadossi's research works | Boston Pharmaceuticals, Cambridge and other places
Medica RCP | HCP
DEF 14A
Jean-Pierre Sommadossi's research works | Boston Pharmaceuticals, Cambridge and other places
11 | janvier | 2013 | Café des Sciences de Boston
Craig Cameron Lab on Twitter: "Honored to receive the inaugural @ISARICAR Diversity Speaker Award tonight. https://t.co/GRrmJWCs8P" / Twitter
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
Jean-Pierre Sommadossi, Atea Pharmaceuticals Inc: Profile and Biography - Bloomberg Markets
中華民國製藥發展協會
Jean Sommadossi - Founder & Chief Executive Officer @ Idenix Pharmaceuticals - Crunchbase Person Profile
Jean-Pierre Sommadossi, Founder, Chief Executive Officer and Chairman, Atea Pharmaceuticals
Jean-Pierre Sommadossi's research works | Boston Pharmaceuticals, Cambridge and other places
CORPORATE FACT SHEET
Café des Entrepreneurs le 18 février 2017! - Consulat Général de France à Boston
![Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20200331956/US20200331956A1-20201022-C00002.png "Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]")
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]
Jean-Pierre Sommadossi, PhD - Atea Pharmaceuticals
Jean-Pierre Sommadossi, Founder, Chief Executive Officer and Chairman, Atea Pharmaceuticals
thebenefactor
Our Team - Atea Pharmaceuticals
Jean-Pierre Sommadossi, chairman and chief executive of Idenix... News Photo - Getty Images
Our Team - Atea Pharmaceuticals
thebenefactor
Dr. Jean-Pierre Sommadossi Ph.D. Net Worth (2023) | wallmine
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
